Labetalol Infusion in Acute Myocardial Infarction with Systemic Hypertension
Overview
Affiliations
1 Fifteen patients with suspected acute myocardial infarction and systemic BP of greater than 160/110 mmHg were treated with an incremental infusion of labetalol. 2 Systemic BPs were safely and effectively lowered to less than 130 mm Hg systolic or 90 mmHg diastolic in all pateints. 3 Heart rate, mean pulmonary artery wedge pressure cardiac index and stroke work index were significantly reduced. 4 The dose of labetalol varied from 30 mg--440 mg and was significantly higher (mean 295 mg) in those patients with pre-existing systemic hypertension compared with others (mean 133 mg). 5 No side-effects occurred and all patients survived to leave hospital.
Hypertensive crisis in children: an experience in a single tertiary care center in Korea.
Lee G, Lee I, Park S, Kim J, Oh J, Shin J Clin Hypertens. 2016; 22:10.
PMID: 27092268 PMC: 4834822. DOI: 10.1186/s40885-016-0040-2.
Perioperative hypertension management.
Varon J, Marik P Vasc Health Risk Manag. 2008; 4(3):615-27.
PMID: 18827911 PMC: 2515421. DOI: 10.2147/vhrm.s2471.
Clinical review: the management of hypertensive crises.
Varon J, Marik P Crit Care. 2003; 7(5):374-84.
PMID: 12974970 PMC: 270718. DOI: 10.1186/cc2351.
The electrophysiological effects of intravenous labetalol in man.
Harley A, Coverdale H Eur J Clin Pharmacol. 1981; 20(4):241-4.
PMID: 7308279 DOI: 10.1007/BF00618772.
Role of labetalol in acute myocardial infarction.
Timmis A, Fowler M, Jaggarao N, Vincent R, Chamberlain D Br J Clin Pharmacol. 1982; 13(1 Suppl):111S-114S.
PMID: 7093093 PMC: 1401843. DOI: 10.1111/j.1365-2125.1982.tb01898.x.